Central control of energy balance by amylin and calcitonin receptor agonists and their potential for treatment of metabolic diseases-Reference-Cited by-同舟云学术

Central control of energy balance by amylin and calcitonin receptor agonists and their potential for treatment of metabolic diseases

Published:2020-05-18 Issue:3 Volume:127 Page:163-177
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharmacol Toxicol

Author:

Zakariassen Hannah Louise¹²^ORCID,John Linu Mary²,Lutz Thomas Alexander³

Affiliation:

1. Section of Experimental Animal Models Department of Veterinary and Animal Science Faculty of Health and Medical Sciences University of Copenhagen Frederiksberg C Denmark

2. Obesity Pharmacology Novo Nordisk A/S Måløv Denmark

3. Institute of Veterinary Physiology University of Zurich Zurich Switzerland

Funder

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcpt.13427

Reference159 articles.

1. Obesity and the Regulation of Energy Balance

2. World Health Organization.Global health observatory (GHO) data ‐ overweight and obesity.2018[updated 2018; cited 2018 18 Oct];http://www.who.int/gho/ncd/risk_factors/overweight_obesity/obesity_adults/en/

3. Mechanisms, Pathophysiology, and Management of Obesity

4. Biological mechanisms that promote weight regain following weight loss in obese humans

5. Neural Control of Energy Balance: Translating Circuits to Therapies

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Pharmaceuticals in Appetite Regulation: Exploring emerging gut peptides and their pharmacological prospects;Pharmacology Research & Perspectives;2024-07-17

2. The processing intermediate of human amylin, pro-amylin(1–48), has in vivo and in vitro bioactivity;Biophysical Chemistry;2024-05

3. Hindbrain REV-ERB nuclear receptors regulate sensitivity to diet-induced obesity and brown adipose tissue pathophysiology;Molecular Metabolism;2024-01

4. Structural insight into selectivity of amylin and calcitonin receptor agonists;Nature Chemical Biology;2023-08-03

5. A new era in gut hormone-based pharmacotherapy for people with obesity;Proceedings of the Nutrition Society;2022-09